Holding at a dose for an extra 4 weeks before escalating is a medically supported strategy when: Nausea or vomiting persists beyond 2 weeks at the current dose You are unable to eat at least 1,000 calories per day comfortably Dehydration symptoms appear (dark urine, dizziness on standing, dry mouth) You are losing weight faster than 1 to 2 pounds per week on the current dose (aggressive weight loss increases side effect risk) In the STEP trials, delayed escalation did not compromise overall weight loss outcomes at 68 weeks
This triple action enhances appetite control, improves metabolism, and increases fat burning more effectively
Live and pasteurized Akkermansia are completely differentincluding their impact on health
This interest has created multiple classes of offerings that are changing the functional food and beverage market
Bottom Line Dry mouth, bad breath, and taste changes can show up with GLP-1s, even without hard proof the medication causes them directly
The hearing provides the court with an early view of the scientific issues that will probably influence future pretrial decisions in the litigation